Clinical Trial Update: A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of osmotic release hydromorphone in non-opioid tolerant Chinese patients with cancer. The document notes the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Hydromorphone (OROS) (hydromorphone)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Pain | Phase 1 | Status: COMPLETED